Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13.8M
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
4.16M
-
Shares change
-
+2.98K
-
Total reported value, excl. options
-
$16.2M
-
Value change
-
+$16.8K
-
Number of buys
-
4
-
Number of sells
-
-7
-
Price
-
$3.88
Significant Holders of CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) as of Q4 2017
17 filings reported holding CSBR - CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share as of Q4 2017.
CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.16M shares
of 13.8M outstanding shares and own 30.08% of the company stock.
Largest 10 shareholders include Battery Partners IX, LLC (1.95M shares), NEA Management Company, LLC (1.56M shares), PERCEPTIVE ADVISORS LLC (387K shares), Vanguard Group Inc (109K shares), RENAISSANCE TECHNOLOGIES LLC (62.1K shares), SHEPHERD KAPLAN KROCHUK, LLC (38.6K shares), DEUTSCHE BANK AG\ (15.4K shares), MILLENNIUM MANAGEMENT LLC (14.2K shares), Sandy Spring Bank (8.33K shares), and WELLS FARGO & COMPANY/MN (4.7K shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.